Investing
The artificial intelligence arms race is entering a new phase as major industry players ramp up investments to keep up with their rivals. In...
Connect with us
Hi, what are you looking for?
Daily Market Solution
- Stock
Orange juice importer says Brazil tariffs will squeeze American consumers
Musk’s brain implant company filed as a ‘disadvantaged business’
A flagging U.S. industry looks for new life in a Philadelphia shipyard
Coca-Cola dodges after Trump says soda will switch back to cane sugar
Trump says it’s ‘highly unlikely’ he will fire Fed Chair after broaching idea with GOP reps
- Economy
- Editor’s Pick
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
American creating deepfakes targeting Harris works with Russian intel, documents show
Early voting in Wisconsin slowed by label printing problems
- Latest News
Jeffrey Epstein case reopens focus on Ghislaine Maxwell as deputy AG steps in
Huckabee hits back at Western countries that ‘side’ with terror group Hamas
Obama denies Trump’s ‘bizarre allegations’ that he was Russiagate ‘ringleader’ in rare statement
‘Not going away’: Inside the Epstein drama that’s thrown House GOP into chaos
GOP lawmakers advocate for US condemnation of persecution against Christians in Muslim-majority nations
Investing
The artificial intelligence arms race is entering a new phase as major industry players ramp up investments to keep up with their rivals. In...
Investing
 Radiopharm Theranostics (ASX:RAD,OTC:RDPTF, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...
Investing
The S&P/TSX Venture Composite Index (INDEXTSI:JX) lost 0.89 points last week to close at 569.82. The US Bureau of Economic Analysis released its latest...